Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients

BackgroundThe aim of this study was to explore the construct validity and diagnostic properties of the Reading the Mind in the Eyes Test (RMET) in non-demented patients with amyotrophic lateral sclerosis (ALS).MaterialsA total of 61 consecutive patients and 50 healthy controls (HCs) were administere...

Full description

Bibliographic Details
Main Authors: Edoardo Nicolò Aiello, Laura Carelli, Federica Solca, Silvia Torre, Roberta Ferrucci, Alberto Priori, Federico Verde, Vincenzo Silani, Nicola Ticozzi, Barbara Poletti
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Psychology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyg.2022.1031841/full
_version_ 1811255295562743808
author Edoardo Nicolò Aiello
Edoardo Nicolò Aiello
Laura Carelli
Federica Solca
Silvia Torre
Roberta Ferrucci
Roberta Ferrucci
Roberta Ferrucci
Alberto Priori
Alberto Priori
Federico Verde
Federico Verde
Vincenzo Silani
Vincenzo Silani
Nicola Ticozzi
Nicola Ticozzi
Barbara Poletti
author_facet Edoardo Nicolò Aiello
Edoardo Nicolò Aiello
Laura Carelli
Federica Solca
Silvia Torre
Roberta Ferrucci
Roberta Ferrucci
Roberta Ferrucci
Alberto Priori
Alberto Priori
Federico Verde
Federico Verde
Vincenzo Silani
Vincenzo Silani
Nicola Ticozzi
Nicola Ticozzi
Barbara Poletti
author_sort Edoardo Nicolò Aiello
collection DOAJ
description BackgroundThe aim of this study was to explore the construct validity and diagnostic properties of the Reading the Mind in the Eyes Test (RMET) in non-demented patients with amyotrophic lateral sclerosis (ALS).MaterialsA total of 61 consecutive patients and 50 healthy controls (HCs) were administered the 36-item RMET. Additionally, patients underwent a comprehensive assessment of social cognition via the Story-Based Empathy Task (SET), which encompasses three subtests targeting Causal Inference, Emotion Attribution (SET-EA), and Intention Attribution (SET-IA), as well as global cognitive [the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)] and behavioral screening [the Frontal Behavioral Inventory (FBI); the Dimensional Apathy Scale (DAS); the Beck Depression Inventory (BDI); and the State and Trait Anxiety Inventory-Y]. The construct validity of the RMET was tested by regressing it within a stepwise model that encompassed as predictors the abovementioned cognitive and behavioral measures, covarying for demographic and motor confounders. Receiver-operating characteristics (ROC) analyses allowed exploring intrinsic and post-test properties of the RMET both in discriminating patients from HCs and in identifying patients with a defective SET-EA performance.ResultsThe RMET was solely predicted by the SET-EA (p = 0.003) and SET-IA (p = 0.005). RMET scores showed high accuracy both in discriminating patients from HCs (AUC = 0.81) and in identifying patients with a defective SET-EA score (AUC = 0.82), with adequate-to-optimal both intrinsic and post-test properties.DiscussionThe RMET is a convergently and divergently valid measure of affective social cognition in non-demented ALS patients, also featuring optimal intrinsic and post-test diagnostic properties in both case-control and case-finding scenarios.
first_indexed 2024-04-12T17:21:47Z
format Article
id doaj.art-7ee03e85b0a74642991b9ce1a3f9b5bc
institution Directory Open Access Journal
issn 1664-1078
language English
last_indexed 2024-04-12T17:21:47Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychology
spelling doaj.art-7ee03e85b0a74642991b9ce1a3f9b5bc2022-12-22T03:23:27ZengFrontiers Media S.A.Frontiers in Psychology1664-10782022-11-011310.3389/fpsyg.2022.10318411031841Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patientsEdoardo Nicolò Aiello0Edoardo Nicolò Aiello1Laura Carelli2Federica Solca3Silvia Torre4Roberta Ferrucci5Roberta Ferrucci6Roberta Ferrucci7Alberto Priori8Alberto Priori9Federico Verde10Federico Verde11Vincenzo Silani12Vincenzo Silani13Nicola Ticozzi14Nicola Ticozzi15Barbara Poletti16IRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, ItalyPh.D. Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, ItalyAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milan, ItalyASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, ItalyIRCCS Ca’ Granda Foundation Maggiore Policlinico Hospital, Milan, ItalyAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milan, ItalyASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, Italy“Dino Ferrari” Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, Italy“Dino Ferrari” Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, Italy“Dino Ferrari” Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalyIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, Milan, ItalyBackgroundThe aim of this study was to explore the construct validity and diagnostic properties of the Reading the Mind in the Eyes Test (RMET) in non-demented patients with amyotrophic lateral sclerosis (ALS).MaterialsA total of 61 consecutive patients and 50 healthy controls (HCs) were administered the 36-item RMET. Additionally, patients underwent a comprehensive assessment of social cognition via the Story-Based Empathy Task (SET), which encompasses three subtests targeting Causal Inference, Emotion Attribution (SET-EA), and Intention Attribution (SET-IA), as well as global cognitive [the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)] and behavioral screening [the Frontal Behavioral Inventory (FBI); the Dimensional Apathy Scale (DAS); the Beck Depression Inventory (BDI); and the State and Trait Anxiety Inventory-Y]. The construct validity of the RMET was tested by regressing it within a stepwise model that encompassed as predictors the abovementioned cognitive and behavioral measures, covarying for demographic and motor confounders. Receiver-operating characteristics (ROC) analyses allowed exploring intrinsic and post-test properties of the RMET both in discriminating patients from HCs and in identifying patients with a defective SET-EA performance.ResultsThe RMET was solely predicted by the SET-EA (p = 0.003) and SET-IA (p = 0.005). RMET scores showed high accuracy both in discriminating patients from HCs (AUC = 0.81) and in identifying patients with a defective SET-EA score (AUC = 0.82), with adequate-to-optimal both intrinsic and post-test properties.DiscussionThe RMET is a convergently and divergently valid measure of affective social cognition in non-demented ALS patients, also featuring optimal intrinsic and post-test diagnostic properties in both case-control and case-finding scenarios.https://www.frontiersin.org/articles/10.3389/fpsyg.2022.1031841/fullReading the Mind in the Eyes Testamyotrophic lateral sclerosisexecutivediagnosticspsychometric
spellingShingle Edoardo Nicolò Aiello
Edoardo Nicolò Aiello
Laura Carelli
Federica Solca
Silvia Torre
Roberta Ferrucci
Roberta Ferrucci
Roberta Ferrucci
Alberto Priori
Alberto Priori
Federico Verde
Federico Verde
Vincenzo Silani
Vincenzo Silani
Nicola Ticozzi
Nicola Ticozzi
Barbara Poletti
Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
Frontiers in Psychology
Reading the Mind in the Eyes Test
amyotrophic lateral sclerosis
executive
diagnostics
psychometric
title Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
title_full Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
title_fullStr Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
title_full_unstemmed Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
title_short Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients
title_sort validity and diagnostics of the reading the mind in the eyes test rmet in non demented amyotrophic lateral sclerosis als patients
topic Reading the Mind in the Eyes Test
amyotrophic lateral sclerosis
executive
diagnostics
psychometric
url https://www.frontiersin.org/articles/10.3389/fpsyg.2022.1031841/full
work_keys_str_mv AT edoardonicoloaiello validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT edoardonicoloaiello validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT lauracarelli validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT federicasolca validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT silviatorre validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT robertaferrucci validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT robertaferrucci validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT robertaferrucci validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT albertopriori validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT albertopriori validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT federicoverde validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT federicoverde validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT vincenzosilani validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT vincenzosilani validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT nicolaticozzi validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT nicolaticozzi validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients
AT barbarapoletti validityanddiagnosticsofthereadingthemindintheeyestestrmetinnondementedamyotrophiclateralsclerosisalspatients